Advertisement

Commentary RE: Effect of Radical Prostatectomy for Prostate Cancer on Patient Quality of Life: Results From a Medicare Survey

      In the early 1990s, the increasingly widespread use of prostate-specific antigen as a screening test resulted in an impressive “spike” in the incidence of prostate cancer, unprecedented in the history of oncology. Men with clinically localized cancers facing treatment generally had to decide among radical prostatectomy, external beam radiation therapy, and some form of expectant management. Our group had documented that rates of radical prostatectomy among Medicare beneficiaries increased 5-fold between 1984 and 1990.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Graves EJ
        Detailed diagnoses and procedures. National Hospital Discharge Survey, 1990. National Center for Health Statistics.
        Vital Health Stat. 1992; 13: 116
        • Jonler M
        • Messing EM
        • Rhodes PR
        • Bruskewitz RC
        Sequelae of radical prostatectomy.
        Br J Urol. 1994; 74: 132-358
        • Fowler FJ
        • Barry MJ
        • Lu-Yao G
        • Wasson J
        • Roman A
        • Wennberg J
        Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey.
        Urology. 1995; 45: 1007-1013
        • Fowler FJ
        • Barry MJ
        • Lu-Yao G
        • Wasson JH
        • Bin L
        Outcomes of external-beam radiation therapy for prostate cancer: a study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas.
        J Clin Oncol. 1996; 14: 2258-2265
        • Hoffman RM
        • Lo M
        • Clark JA
        • et al.
        Treatment decision regret among long-term survivors of localized prostate cancer: results from the prostate cancer outcomes study.
        J Clin Oncol. 2017; 35: 2306-2314
      1. All-Payer Claims Databases. Content last reviewed February 2018. Agency for Healthcare Research and Quality, Rockville, MD. Available at: https://www.ahrq.gov/professionals/quality-patient-safety/quality-resources/apcd/index.html. Accessed August 11, 2019.